German Pharma Sector Analysis
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Apr, 2010| No. of Pages : 30
List of Figures:
Figure 3-1: Leading Causes of Death (%), 2009
Figure 4-1: Pharmaceutical Market (Billion Euro), 2008-2012
Figure 4-2: Branded Drugs Market (Billion Euro), 2008-2012
Figure 4-3: Generic Drugs Market (Billion Euro), 2008-2012
Figure 4-4: Share of Branded and Generic Drugs in Pharmaceutical Market (Value Terms), 2009
Figure 4-5: Share of Branded and Generic Drugs in Pharmaceutical Market (Volume Terms), 2009
Figure 4-6: Share of Export in Total Pharmaceutical Market (2009)
List of Tables:
Table 7-1: Recent M&As in Pharmaceutical Market
Table 7-2: Bayer Schering Pharma - Strengths & Weaknesses
Table 7-3: Pfizer Inc. - Strengths & Weaknesses
Table 7-4: Boehringer Ingelheim - Strengths & Weaknesses
Table 7-5: Abbott Laboratories - Strengths & Weaknesses
Table 7-6: Novartis - Strengths & Weaknesses